These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 25248971

  • 1. Targeting brain α7 nicotinic acetylcholine receptors in Alzheimer's disease: rationale and current status.
    Vallés AS, Borroni MV, Barrantes FJ.
    CNS Drugs; 2014 Nov; 28(11):975-87. PubMed ID: 25248971
    [Abstract] [Full Text] [Related]

  • 2. α7 Nicotinic receptor agonist enhances cognition in aged 3xTg-AD mice with robust plaques and tangles.
    Medeiros R, Castello NA, Cheng D, Kitazawa M, Baglietto-Vargas D, Green KN, Esbenshade TA, Bitner RS, Decker MW, LaFerla FM.
    Am J Pathol; 2014 Feb; 184(2):520-9. PubMed ID: 24269557
    [Abstract] [Full Text] [Related]

  • 3. Positive allosteric modulators of alpha 7 nicotinic acetylcholine receptors enhance procognitive effects of conventional anti-Alzheimer drugs in scopolamine-treated rats.
    Potasiewicz A, Krawczyk M, Gzielo K, Popik P, Nikiforuk A.
    Behav Brain Res; 2020 May 15; 385():112547. PubMed ID: 32087183
    [Abstract] [Full Text] [Related]

  • 4. Beyond acetylcholinesterase inhibitors for treating Alzheimer's disease: α7-nAChR agonists in human clinical trials.
    Russo P, Del Bufalo A, Frustaci A, Fini M, Cesario A.
    Curr Pharm Des; 2014 May 15; 20(38):6014-21. PubMed ID: 24641224
    [Abstract] [Full Text] [Related]

  • 5. Restoring long-term potentiation impaired by amyloid-beta oligomers: comparison of an acetylcholinesterase inhibitior and selective neuronal nicotinic receptor agonists.
    Kroker KS, Moreth J, Kussmaul L, Rast G, Rosenbrock H.
    Brain Res Bull; 2013 Jul 15; 96():28-38. PubMed ID: 23639920
    [Abstract] [Full Text] [Related]

  • 6. Muscarinic and nicotinic acetylcholine receptor agonists: current scenario in Alzheimer's disease therapy.
    Verma S, Kumar A, Tripathi T, Kumar A.
    J Pharm Pharmacol; 2018 Aug 15; 70(8):985-993. PubMed ID: 29663387
    [Abstract] [Full Text] [Related]

  • 7. The combination of memantine and galantamine improves cognition in rats: The synergistic role of the α7 nicotinic acetylcholine and NMDA receptors.
    Nikiforuk A, Potasiewicz A, Kos T, Popik P.
    Behav Brain Res; 2016 Oct 15; 313():214-218. PubMed ID: 27435422
    [Abstract] [Full Text] [Related]

  • 8. Positive allosteric modulators of α7 nicotinic acetylcholine receptors affect neither the function of other ligand- and voltage-gated ion channels and acetylcholinesterase, nor β-amyloid content.
    Arias HR, Ravazzini F, Targowska-Duda KM, Kaczor AA, Feuerbach D, Boffi JC, Draczkowski P, Montag D, Brown BM, Elgoyhen AB, Jozwiak K, Puia G.
    Int J Biochem Cell Biol; 2016 Jul 15; 76():19-30. PubMed ID: 27129924
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. What is the rationale for new treatment strategies in Alzheimer's disease?
    Rogawski MA.
    CNS Spectr; 2004 Jul 15; 9(7 Suppl 5):6-12. PubMed ID: 15241294
    [Abstract] [Full Text] [Related]

  • 12. Nicotinic Cholinergic Mechanisms in Alzheimer's Disease.
    Shen J, Wu J.
    Int Rev Neurobiol; 2015 Jul 15; 124():275-92. PubMed ID: 26472533
    [Abstract] [Full Text] [Related]

  • 13. [Therapy of Alzheimer disease].
    Kovács T.
    Neuropsychopharmacol Hung; 2009 Mar 15; 11(1):27-33. PubMed ID: 19731816
    [Abstract] [Full Text] [Related]

  • 14. Targeting α7 nicotinic acetylcholine receptors and their protein interactions in Alzheimer's disease drug development.
    Burns LH, Pei Z, Wang HY.
    Drug Dev Res; 2023 Sep 15; 84(6):1085-1095. PubMed ID: 37291958
    [Abstract] [Full Text] [Related]

  • 15. Role of Alpha-7-Nicotinic Acetylcholine Receptor in Alzheimer's Disease.
    Singh S, Agrawal N, Goyal A.
    CNS Neurol Disord Drug Targets; 2024 Sep 15; 23(3):384-394. PubMed ID: 37366362
    [Abstract] [Full Text] [Related]

  • 16. Effect of huprine X on β-amyloid, synaptophysin and α7 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice.
    Hedberg MM, Clos MV, Ratia M, Gonzalez D, Lithner CU, Camps P, Muñoz-Torrero D, Badia A, Giménez-Llort L, Nordberg A.
    Neurodegener Dis; 2010 Sep 15; 7(6):379-88. PubMed ID: 20689242
    [Abstract] [Full Text] [Related]

  • 17. Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer's disease.
    Karthick C, Nithiyanandan S, Essa MM, Guillemin GJ, Jayachandran SK, Anusuyadevi M.
    Neurol Res; 2019 Feb 15; 41(2):139-150. PubMed ID: 30453864
    [Abstract] [Full Text] [Related]

  • 18. Galantamine-induced amyloid-{beta} clearance mediated via stimulation of microglial nicotinic acetylcholine receptors.
    Takata K, Kitamura Y, Saeki M, Terada M, Kagitani S, Kitamura R, Fujikawa Y, Maelicke A, Tomimoto H, Taniguchi T, Shimohama S.
    J Biol Chem; 2010 Dec 17; 285(51):40180-91. PubMed ID: 20947502
    [Abstract] [Full Text] [Related]

  • 19. Advances in the discovery of novel positive allosteric modulators of the alpha7 nicotinic acetylcholine receptor.
    Faghih R, Gfesser GA, Gopalakrishnan M.
    Recent Pat CNS Drug Discov; 2007 Jun 17; 2(2):99-106. PubMed ID: 18221220
    [Abstract] [Full Text] [Related]

  • 20. Modulation of α7 nicotinic acetylcholine receptor and fibrillar amyloid-β interactions in Alzheimer's disease brain.
    Ni R, Marutle A, Nordberg A.
    J Alzheimers Dis; 2013 Jun 17; 33(3):841-51. PubMed ID: 23042213
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.